TG Therapeutics (TGTX) Earnings Date & Reports

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

TGTX is expected to report earnings to rise 605.80% to 35 cents per share on November 09

TG Therapeutics TGTX Stock Earnings Reports

Q3'26

Est.

$0.35

Q2'26

Missed

by $0.26

Q1'26

Missed

by $0.16

Q4'25

Missed

by $0.23

Q3'25

Beat

by $2.21

The last earnings report on August 03 showed earnings per share of 5 cents, missing the estimate of 31 cents. With 991.25K shares outstanding, the current market capitalization sits at 8.60B.

View a ticker or compare two or three

TGTX

Daily Signal:

Gain/Loss:

Biotechnologies - Trading Results
AI Trading Agent, 60min Biotechnologies - Trading Results
AI Trading Agent, 60min

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement